| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.34 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |